Other OTC - Delayed Quote • USD
Bayer Aktiengesellschaft (BAYZF)
At close: April 19 at 3:45 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
47,637,000.00
47,637,000.00
50,739,000.00
44,081,000.00
41,400,000.00
Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Gross Profit
27,888,000.00
27,888,000.00
30,868,000.00
27,265,000.00
22,262,000.00
Operating Expense
19,852,000.00
19,852,000.00
23,535,000.00
20,356,000.00
22,976,000.00
Operating Income
8,036,000.00
8,036,000.00
7,333,000.00
6,909,000.00
-714,000.00
Net Non Operating Interest Income Expense
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
Pretax Income
-1,621,000.00
-1,621,000.00
4,670,000.00
2,046,000.00
-17,250,000.00
Tax Provision
1,321,000.00
1,321,000.00
504,000.00
1,024,000.00
-1,689,000.00
Net Income Common Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Diluted NI Available to Com Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Basic EPS
-2.99
--
4.22
1.02
-10.68
Diluted EPS
-2.99
--
4.22
1.02
-10.68
Basic Average Shares
982,420.00
--
982,420.00
982,420.00
982,420.00
Diluted Average Shares
982,420.00
--
982,420.00
982,420.00
982,420.00
Total Expenses
39,601,000.00
39,601,000.00
43,406,000.00
37,172,000.00
42,114,000.00
Net Income from Continuing & Discontinued Operation
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Normalized Income
10,068,750.00
10,068,750.00
5,304,132.00
3,507,400.00
156,606.00
Interest Income
484,000.00
484,000.00
379,000.00
346,000.00
202,000.00
Interest Expense
2,047,000.00
2,047,000.00
1,857,000.00
1,347,000.00
1,596,000.00
Net Interest Income
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
EBIT
426,000.00
426,000.00
6,527,000.00
3,393,000.00
-15,654,000.00
EBITDA
10,446,000.00
10,446,000.00
13,030,000.00
6,449,000.00
-2,395,000.00
Reconciled Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Reconciled Depreciation
10,020,000.00
10,020,000.00
6,503,000.00
3,056,000.00
13,259,000.00
Net Income from Continuing Operation Net Minority Interest
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-15,569,000.00
Total Unusual Items Excluding Goodwill
-7,435,000.00
-7,435,000.00
-471,000.00
-3,582,000.00
-14,953,000.00
Total Unusual Items
-745,000.00
-745,000.00
263,000.00
-3,582,000.00
-12,715,000.00
Normalized EBITDA
11,191,000.00
11,191,000.00
12,767,000.00
10,031,000.00
10,320,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,115,250.00
-1,115,250.00
-50,868.00
-1,074,600.00
-1,465,394.00
12/31/2020 - 2/13/2009
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
TTKHLTCARE.NS TTK Healthcare Limited
1,524.90
-0.23%
SNYNF Sanofi
92.70
0.00%
DSKYF Daiichi Sankyo Company, Limited
30.30
+1.85%
LLY.F Eli Lilly and Company
682.20
-2.90%
RHHBF Roche Holding AG
254.50
-3.23%
GLAXF GSK plc
20.20
0.00%
PFE.F Pfizer Inc.
24.22
+2.00%
JNJ.F Johnson & Johnson
137.20
+0.81%
RHHVF Roche Holding AG
243.98
+1.63%
DSNKY Daiichi Sankyo Company, Limited
30.18
+2.03%